Rodrigo Seira

Cooley advised Accolade on its $253.6 million initial public offering of 11,526,134 shares of common stock, including full exercise of the underwriters’ option to purchase additional shares. Accolade, whose securities now trade on the Nasdaq Global Select Market under the symbol “ACCD,” is a healthcare technology company that provides personalized healthcare services and benefits solutions to employees using a range of technologies. Partners John Robertson and Alan Hambelton led the Cooley team.

Cooley advised Riverwood Capital on leading Nium’s $200 million+ Series D financing round, which brings the Singapore-based business payments company’s valuation to more than $1 billion. Partners Matthew Bartus and Adam Dinow led the international Cooley team advising Riverwood Capital on the transaction, which makes Nium the first business-to-business (B2B) unicorn in Southeast Asia.